Beta-adrenoceptor antagonists: studies on behaviour (delayed differentiation) in the monkey (Macaca mulatta).

Area of Science:

• Pharmacology
• Neuroscience
• Behavioral Science

Background:

• Beta-adrenoceptor antagonists are widely used medications.
• Understanding their central nervous system (CNS) effects is crucial for patient safety.
• Differential effects based on lipophilicity may exist.

Purpose of the Study:

• To compare the behavioral effects of lipophilic and hydrophilic beta-adrenoceptor antagonists in a primate model.
• To assess the impact of these drugs on cognitive tasks, specifically delayed differentiation.
• To determine if drug lipophilicity correlates with CNS activity.

Main Methods:

• Six beta-adrenoceptor antagonists (3 lipophilic: propranolol, oxprenolol, metoprolol; 3 hydrophilic: acebutolol, atenolol, sotalol) were administered intraperitoneally to Macaca mulatta monkeys.
• Behavioral activity was assessed using a delayed differentiation task.
• Doses ranged from 5 to 30 mg/kg.

Main Results:

• Lipophilic antagonists (propranolol, oxprenolol, metoprolol) generally increased response time and decreased correct responses, indicating CNS effects.
• Hydrophilic antagonists (atenolol, acebutolol) showed fewer or no significant behavioral effects at the tested doses.
• Propranolol exhibited the most pronounced effects, while atenolol and acebutolol had the least.

Conclusions:

• Lipophilic beta-adrenoceptor antagonists are more likely to exert effects on the central nervous system.
• Hydrophilic beta-adrenoceptor antagonists may primarily affect the peripheral nervous system.
• Atenolol and acebutolol demonstrate potential utility in clinical settings where avoidance of CNS disturbances is desired.